Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136727) titled 'AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001)' on Aug. 9.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Condition:
Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)
Intervention:
Other: AI-assisted comprehensive management system
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 15, 2025
Target Sample Size: 5000
Countri...